TOI — Oncology Institute Share News
0.000.00%
Last trade - 00:00- $525.91m
- $574.24m
- $502.73m
Brief: Oncology Institute Sees 2023 Revenue Of $290 To $320 Million
Brief: Oncology Institute Q1 revenue USD 76 million
Brief: The Oncology Institute Reports First Quarter 2023 Financial Results And Reaffirms Full Year 2023 Guidance
Brief: Oncology Institute - On April 25, Co Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Corrected: BRIEF-(OFFICIAL)-Oncology Institute Q4 revenue USD 71 million (Mar.9)
Oncology Institute Inc reports results for the quarter ended in December - Earnings Summary
Brief: The Oncology Institute Reports Fourth Quarter And Full Year 2022 Financial Results
Brief: Oncology Institute Q4 revenue USD 71 million
Oncology Institute Inc expected to post a loss of 18 cents a share - Earnings Preview
Brief: Oncology Institute Rebrands Clinical Trials Division
Oncology Institute Inc reports results for the quarter ended in September - Earnings Summary
Brief: The Oncology Institute Reports Third Quarter 2022 Financial Results
Oncology Institute Inc expected to post a loss of 18 cents a share - Earnings Preview
Brief: The Oncology Institute Enrolls Nation’S First Two Patients In A Phase 3 Open-Label, Randomized Clinical Trial Of Pirtobrutinib
Brief: The Oncology Institute Appoints Two New Board Members
Brief: Oncology Institute Becomes Certified As Patient Safety Organization
Brief: Oncology Institute Inc Partners With Blue Note Therapeutics To Provide Digital Therapeutic For Treating Cancer-Related Anxiety And Depression Symptoms
Brief: Oncology Institute Q2 Revenue Rose 22.2% To $61 Mln
Brief: The Oncology Institute Announces $110 Mln Strategic Investment By Deerfield Management To Accelerate Expansion Into New Markets